|
|
||||||||
1 Department of In Vivo NMR
Spectroscopy, Hearts of wild-type and cytosolic muscle
creatine kinase (M-CK)-knockout mice were perfused with Krebs-Henseleit
buffer containing 10 mM glucose and 5 mM pyruvate and studied during
pacing at 400 and 600 beats/min and during
K+ arrest. Phosphocreatine (PCr)
and ATP concentrations in M-CK-deficient hearts were not significantly
different from those in wild-type hearts. With the use of
31P NMR saturation transfer, the
flux mediated predominantly by mitochondrial creatine kinase (Mi-CK)
was clearly detected in M-CK-deficient hearts. Mi-CK flux was 4.8 ± 0.6 and 4.5 ± 0.6 mM/s during pacing at 400 and 600 beats/min,
respectively, and was 3.5 ± 0.4 mM/s during cardiac arrest. In
control hearts total CK flux was 7.8 ± 1.1 and 6.6 ± 1.3 mM/s
during pacing at 400 and 600 beats/min, respectively, and decreased to
3.8 ± 0.5 mM/s during arrest. It is suggested that the relative
contribution of Mi-CK to the total NMR-measured CK flux in the
wild-type heart is higher than that of the homodimeric M-CK isoform
(MM-CK).
enzyme kinetics; transgenic mice; phosphocreatine; magnetic
resonance spectroscopy; energy metabolism
CREATINE KINASE (CK) is an enzyme thought
to be critically involved in intracellular energy homeostasis. It
catalyzes the reversible transfer of a high-energy phosphoryl group
between ATP and creatine (Cr): phosphocreatine
(PCr)2 The primary and well-recognized role of this reaction is to maintain a
constant level of cytosolic ATP and a low cytosolic free ADP level,
particularly when ATP hydrolysis temporarily exceeds ATP synthesis.
Biochemical studies revealed the existence of different mammalian CK
isoforms, which are distributed in a tissue-dependent manner and are
located in different cellular compartments (see Ref. 38 for review).
Invariably, at least one type of cytosolic CK is coexpressed with a
mitochondrially localized CK isoform (Mi-CK) (39). In cardiac muscle at
least 70% of CK activity resides in the cytosol, primarily as the
homodimeric MM-CK species and partly as the heterodimeric MB-CK
isoform. The remainder is represented by a specific mitochondrial type
of CK. Mi-CK primarily forms octamers in vivo and is localized along
the outer leaflet of the mitochondrial inner membrane and at sites
where the outer and inner mitochondrial membranes are in close vicinity
(39). The various CK isoforms seem to be functionally associated with free-energy producing and delivering processes in the cell (38). A
fraction of MM-CK activity is specifically localized to subcellular structures such as the myofibrillar M band (38), glycolytic enzyme
complexes, and the sarcoplasmic reticulum (38). Mi-CK preferentially
uses ATP produced via mitochondrial oxidative phosphorylation because
of functional coupling with the adenine nucleotide translocase (39).
Hence, PCr leaving the mitochondrion and Cr entering it are thought to
be the principal metabolites connecting sites of ATP delivery and ATP
utilization through diffusion (38). This so-called "CK/PCr
shuttle" concept emphasizes not only temporal energy buffering but
also energy transport via PCr. The CK/PCr shuttle concept relies mostly
on data obtained in vitro, whereas its critical role in energy
metabolism in vivo has not yet been convincingly demonstrated.
Noninvasive 31P NMR methods have
been used extensively to study the importance of the CK system for
energy metabolism in intact tissue. Notably,
31P magnetization-transfer
techniques have proven useful to assess CK-mediated flux in muscle at
rest and in response to changes in workload (6). Whether a direct
correlation between CK flux and ATP synthesis rate is crucial for
muscle function is still a matter of debate. In the perfused heart CK
flux has been shown to increase with elevated workload (4, 5, 22, 26,
28, 29). By contrast, in the in vivo paced mammalian heart (2) and in
skeletal muscle (8, 31) CK flux remains unchanged or, in the latter,
even slightly decreases with elevated ATPase activity and oxidative ATP
synthesis rate.
Thus far, how individual CK isoenzymes contribute to the total
CK-related flux measured by NMR magnetization-transfer techniques has
remained obscure. Mathematical analysis of transient
31P NMR saturation-transfer data
of neonatal rabbit hearts by Zahler and Ingwall (40) provided estimates
for the Mi-CK flux that predicted that this would increase linearly
with ATP synthesis rate. Intuitively, this would seem to agree with the
CK/PCr shuttle model, which suggests intimate coupling of Mi-CK
activity with mitochondrial ATP synthesis. However, so far, direct
experimental evidence to substantiate this point is not available.
Interesting progress in CK research has recently evolved from novel
advances in gene technology (21, 33, 34). Wieringa and co-workers (33,
34) succeeded in creating mouse strains that are homozygous for the
targeted disruption of the gene encoding for a specific CK isoenzyme.
These knockout models permit exciting new studies into the functional
importance of the individual CK isoenzymes. In M-CK-deficient hindlimb
skeletal muscle, in which 2% of the wild-type CK activity remains
represented by Mi-CK, Van Deursen et al. (33) recently did not detect
(Mi-)CK flux by inversion-transfer
31P NMR.
In the present study we measured the kinetics of CK in isolated,
perfused hearts of M-CK-deficient mice. The high capacity for oxidative
ATP synthesis and the relatively high percentage of Mi-CK isozyme
suggest a prominent role for the CK/PCr shuttle in the wild-type heart
(38). In the M-CK-deficient heart such a CK/PCr shuttle can no longer
exist. By applying 31P NMR and
saturation transfer to investigate (Mi-)CK flux and metabolic changes
in response to altered cardiac performance, we particularly aimed at
gathering information about the kinetics of Mi-CK and its function in
cardiac energy metabolism.
Langendorff perfusion.
Hearts were isolated from male wild-type C57Bl and M-CK-deficient mice
(33) weighing ~30 g. The mice were anesthetized through inhalation of
diethyl ether. After heparinization, the heart was rapidly excised and
rinsed in ice-cold buffer. The heart was subsequently perfused through
an aortic cannula. The prefiltered perfusate, a modified
Krebs-Henseleit medium, contained (in mM) 124 NaCl, 4.7 KCl, 1.3 CaCl2, 1.0 MgCl2, and 24 NaHCO3, as well as 10 glucose and
5 Na-pyruvate as substrates, and was continuously bubbled with 95%
O2-5%
CO2 gas, resulting in a pH of 7.35 at 37°C. The heart was perfused at a constant temperature of
37°C, maintained through a circulating water bath, and at constant
hydrostatic pressure of 76 mmHg. A fluid-filled catheter was inserted
via the mitral valve, passed through the apex, and connected to a Gould-Statham P23 Db pressure transducer for monitoring left
ventricular developed pressure (LVDP) and heart rate. Two small copper
pace electrodes were attached to the right ventricular outflow tract (10). The heart was then carefully placed into an NMR tube of 10-mm
diameter together with a small glass capillary containing methylene
diphosphonate (MDP) for spectral reference and calibration. The
perfusate effluent was removed from the NMR tube using a peristaltic pump, keeping the liquid level well above the heart and the NMR detection coils. The perfusate flow rate was measured at regular intervals.
31P NMR spectroscopy.
31P NMR spectra were recorded at
202.5 MHz on a Bruker AM500 spectrometer interfaced to an Aspect 3000 computer and a vertical 11.7-T superconducting magnet. All spectra were
obtained using quadrature detection, a 90° (35 µs) flip angle, a
sweep width of 11,905 Hz, and 2,048 data points, without proton
decoupling. The magnetic field was homogenized by shimming on the
1H signal of water, resulting in
typical line widths of 8-12 Hz. First, a fully relaxed
31P NMR spectrum was recorded from
64 scans with an interpulse delay of 10 s. Next, a transient
31P NMR saturation-transfer
protocol was employed by selectively irradiating the Kinetic analysis.
Time-dependent 31P NMR
magnetization transfer was used to determine the pseudo first-order
unidirectional rate constants for the forward CK reaction, as described
previously (5, 11). The relationship between the PCr signal
[Mt(PCr)] and the
time of
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
+ MgADP
+ H+
Cr + MgATP2
.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-ATP resonance
for specific durations and observing the PCr signal. Analysis of the
exponential decrease of the PCr peak area with saturation time gave an
estimate for the pseudo first-order rate constant
(kfor) of
PCr-to-ATP exchange (see Kinetic analysis). Selective saturation was
achieved by applying a delays alternated with nutations for tailored
excitation (DANTE) pulse sequence with 0.8-µs pulses and a 125-µs
interpulse delay. The durations of the selective
irradiation at the
-ATP resonance were 0, 0.3, 0.6, 1.5, 3.0, and
6.0 s, and it was applied randomly to minimize any effects of aging of
the preparation, which might lead to overestimation of the calculated
flux. The total repetition time remained constant at 6.1 s. Finally, a
control experiment was performed in which the selective irradiation (6 s) was placed at a frequency (
) downfield from the PCr resonance
[
(PCr)
(
-ATP)]. Direct radio frequency
spillover was generally <10%. The full characterization of a heart
at one workload level typically lasted 52 min. Each heart was studied
successively at 400 and 600 beats/min and during cardiac arrest. Full
diastolic arrest was induced by switching to a perfusate in which the
KCl concentration had been increased to 20 mM with an equivalent
decrease in the NaCl content. Before NMR data collection was started,
the heart was allowed to adapt to each new performance level for ~10
min. Workload is expressed as rate-pressure product (RPP), i.e., heart rate × LVDP. The intracellular pH was assessed from the chemical shift difference between intracellular
Pi and PCr, as described previously (13). The intracellular free
Mg2+ concentration
([Mg2+]) was estimated
from the chemical shift difference between the
- and
-ATP
resonances as described before (20).
-ATP saturation was analyzed by a monoexponential fit,
according to the equation
where M0(PCr) is the
magnetization of PCr in the absence of
(1)
-ATP saturation,
kfor is the
forward CK rate constant (in
s
1), and
T1app is the apparent longitudinal
relaxation time (in s), measured in the presence of
-ATP saturation.
The intrinsic longitudinal relaxation time
(T1intr), which would be T1 in
the absence of phosphate exchange, was calculated from the relation T1
1app = T1
1intr + kfor.
Spectral analysis. 31P NMR signals were quantified by iterative fitting of the time-domain signal with the method of variable projection (VARPRO), using prior knowledge (32).
Enzyme activities and metabolite determinations. After the NMR experiment each heart was blotted and weighed to obtain wet weight and then dried in an oven at 80°C for at least 24 h and weighed again to obtain dry weight. Hearts from a different set of animals, but from the same strain, were used for biochemical assays. For that purpose, hearts were rapidly excised and immediately freeze-clamped in liquid N2-cooled tongs and stored in liquid N2 until use. For measurement of CK activity, hearts were allowed to warm up to 4°C in homogenization buffer (10% wt/vol), containing (in mM) 200 mannitol, 30 sucrose, 25 HEPES (pH 7.1), 1 EDTA, and 10 Mg-acetate with 0.1% Triton X-100. The tissue was homogenized at 650 rpm in a Potter-Elvehjem homogenizer and then centrifuged for 5 min at 550 g. The remaining supernatant was assayed spectrophotometrically for CK activity, using a coupled enzyme assay at pH 7.1 and 30°C. Details of the assay have been described previously (35). For metabolite assays, the frozen hearts were pulverized in a dry ice-cooled porcelain mortar and extracted with ice-cold perchloric acid (5% wt/vol). The extract was centrifuged for 2 min at 12,000 g, neutralized by addition of 2 M KOH in 100 mM Tris, and stored in liquid N2. ATP and PCr were determined spectrophotometrically, using standard coupled enzyme assays at pH 6.7 (24). The Cr concentration was determined using a spectrophotometric assay (3). Total Cr (TCr) levels were determined by summation of the PCr and Cr concentrations. Metabolite concentrations were calculated on the assumption that the intracellular water volume is 0.47 ml/g tissue wet wt (1).
Statistics. Differences between parameters of wild-type and mutant animals were analyzed using an unpaired Student's t-test. Multiple comparisons were made by the multiple-range test of Bonferroni if a significant effect was found by one-way or two-way analysis of variance. Differences were considered significant if P < 0.05. Data are presented as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
Tissue mass. After perfusion the mouse hearts were blotted dry and weighed. Transgenic hearts had a wet weight of 180 ± 10 mg (n = 10), and control hearts were 175 ± 15 mg (n = 16). Wild-type and M-CK-knockout hearts were found to have equal wet weight-to-dry weight ratios, namely 5.24 ± 0.14 (n = 16) and 5.13 ± 0.16 (n = 10), respectively. Recently, equal heart weight-to-body weight ratios have been reported for these mice (36, 37).
CK activities and metabolites.
The hearts of wild-type and M-CK-deficient mice were analyzed
biochemically to assess the activity of CK. The CK activity at 37°C
in wild-type hearts was 39.4 ± 4.1 mM/s
(n = 7) compared with 10.4 ± 0.8 mM/s (n = 7) in M-CK-deficient hearts.
Thus the CK activity in M-CK-deficient hearts was reduced to ~26% of
the wild-type level. These activities are somewhat higher for both types of hearts than those recently reported (36), which is possibly
caused by the fact that we included 0.1% Triton X-100 in our medium
for more efficient homogenization. It was previously reported that
knocking out the gene for M-CK does not cause elevated expression of
Mi-CK in either heart ventricles or skeletal muscles (36). In some
M-CK-deficient ventricles a small increase in cytosolic brain CK
activity has been observed (33, 36), which was on average
10% of the
total CK activity in these hearts, so that 90% of the CK activity
resides in the mitochondrion.
|
Physiological parameters. Left ventricular diastolic and systolic pressures were measured continuously. No overt discrepancies between wild-type and M-CK-deficient hearts in either of these parameters were observed. At 400 beats/min, the average LVDP was 70 ± 6 mmHg (n = 7) in wild-type hearts and 74 ± 7 mmHg (n = 6) in transgenic hearts. At 600 beats/min, the average LVDP was 55 ± 4 mmHg (n = 6) in control hearts and 58 ± 6 mmHg (n = 6) in M-CK-deficient hearts.
Response of high-energy phosphate metabolism to workload changes. Hearts were studied by 31P NMR during 400 and 600 beats/min pacing and KCl-induced cardiac arrest, successively. At the highest heart rate, the RPP was ~34,000 mmHg/min in normal as well as in transgenic hearts. Previous studies on perfused rat and rabbit hearts have indicated that RPP is linearly correlated with myocardial oxygen consumption rate (12). Figure 1 shows typical 31P NMR spectra of wild-type and M-CK-deficient hearts at different workloads. The spectra demonstrate that workload-related alterations in the levels of phosphate metabolites were small in both wild-type and M-CK-deficient perfused hearts. The NMR-observed PCr-to-ATP ratio (PCr/ATP) in transgenic hearts was similar to that of wild-type hearts at all workload levels. At 400 beats/min, PCr/ATP was 1.55 ± 0.13 in M-CK-knockout and 1.65 ± 0.13 in wild-type hearts. In both normal and transgenic hearts PCr/ATP was significantly higher during arrest than during pacing at 400 beats/min, i.e., 2.86 ± 0.31 and 2.79 ± 0.07, respectively. PCr/ATP was somewhat higher during 600 beats/min than during 400 beats/min, i.e., 2.52 ± 0.20 in wild-type and 2.00 ± 0.18 in transgenic hearts. The observed differences in PCr/ATP at different work states could be partially explained by somewhat diminished ATP levels in both transgenic hearts and controls. However, this occurred without any concomitant meaningful decline of PCr levels or elevation of Pi levels.
|
1 (25). In wild-type
hearts free cytosolic [ADP] were 33 ± 7 (n = 7), 28 ± 7 (n = 6), and 25 ± 5 (n = 6) µM at 400 and 600 beats/min
pacing and during K+ arrest,
respectively. In the M-CK-knockout hearts free [ADP] were
38 ± 7 (n = 6), 44 ± 3 (n = 6), and 20 ± 7 (n = 5) µM at 400 and 600 beats/min and during K+ arrest,
respectively. Thus free ADP levels tended to decrease on transition
from the beating heart to the arrested state, in particular in the
transgenic hearts. In the transgenic heart free [ADP] was
significantly lower during arrest than during 600 beats/min pacing.
31P NMR saturation-transfer measurements
of CK flux.
Using 31P NMR saturation transfer,
we determined the velocity of CK-mediated exchange between PCr and ATP
in the isolated, perfused heart at the aforementioned three levels of
cardiac performance. Figure 2 shows typical
saturation-transfer spectra of a control heart
(A and
B) and a M-CK-deficient heart
(C and
D), both beating at 400 beats/min;
spectra
C and
D and the difference spectrum (C
D) clearly indicate that Mi-CK,
which is the predominant CK isozyme remaining in the transgenic heart,
catalyzes an appreciable exchange flux. By contrast, Van Deursen et al.
(33) recently did not detect (Mi-)CK flux in the hindlimb skeletal
muscle from these mice. Data from a transient saturation-transfer
protocol were analyzed according to
Eq. 1. Figure
3,
A-C,
shows the exponential decay of the average PCr peak area at
progressively longer saturation times of the
-ATP resonance,
demonstrating magnetization transfer between PCr and ATP in the
M-CK-deficient heart at all work levels examined. Figure 3,
D-F,
shows similar curves for the control heart. A two-parameter exponential
fit to the data according to Eq. 1
yielded values for the pseudo first-order rate constant for the CK
reaction toward ATP synthesis and of the apparent spin-lattice relaxation time (T1app) as
summarized in Table 2. The intrinsic T1
values of PCr (T1intr), i.e., T1
in the absence of PCr-ATP exchange, were calculated and appeared
similar in mutants and controls. The unusually long
T1intr in the arrested control
heart is probably largely caused by the significant error in the
determination of rate constant k and
T1app and is expected to be
similar to the T1intr in beating
control hearts. In beating hearts of control mice, the apparent rate
constant, kfor,
was almost twice as high as in arrested control hearts (Table 2). The
kfor was not
significantly lower in arrested than in beating hearts of
M-CK-deficient mice. In parallel, in control hearts the total
CK-catalyzed flux increased significantly with cardiac performance,
expressed as RPP (Fig. 4). A similar
correlation between CK flux and workload has been observed in perfused
hearts of various other animal species (4, 5, 22, 26, 28, 29). CK flux
did not increase significantly in M-CK-deficient mouse hearts. The
PCr-ATP exchange flux in transgenic hearts was lower than in wild-type
hearts by ~40% at 400 beats/min.
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This study has given important clues about the kinetic behavior of the Mi-CK isozyme through the analysis of its kinetics in the M-CK-deficient mouse heart. In normal tissue the in vivo kinetics of Mi-CK cannot be distinguished from that of the more abundant cytosolic isozyme. However, transgenic hearts that lack M-CK are uniquely suited for study of the kinetic behavior of Mi-CK. Isoenzyme electrophoresis has shown that Mi-CK activity constitutes at least 90% of the total CK activity in the M-CK-knockout heart (33, 36). The remainder is represented by the brain-type homodimeric B-CK (BB-CK) isoform, which is possibly a replacement for the MB isoform found in wild-type hearts. Mi-CK levels in cardiac tissue are not significantly enhanced by the loss of M-CK (33, 36).
To date, the consequences of a knockout of the M-CK gene for myocardial metabolism and function have not been characterized in full detail. The levels of pyruvate kinase and glyceraldehyde-3-phosphate dehydrogenase are significantly increased in M-CK-deficient ventricles, suggesting somewhat enhanced glycolytic activity, although no changes in the activities of adenylate kinase, fructose-6-phosphokinase, or lactate dehydrogenase have been found (37). Ultrastructural data on the transgenic ventricular tissue are not available as yet. Although the M-CK knockout in fast-twitch skeletal muscle led to conspicuous abnormalities, particularly pertaining to the mitochondrial ultrastructure, M-CK-deficient soleus muscle, which like cardiac muscle consists mainly of slow, oxidative fibers, showed neither histochemical nor ultrastructural abnormalities.
M-CK deficiency may be expected to have consequences for heart performance. A fraction of the MM-CK activity is attached to the myofibrils, where it is coupled to the actomyosin ATPase activity, thereby maintaining high and potentially critical (local) ATP-to-ADP ratios during muscle contraction. Our experimental data did not reveal any obvious differences in the performance of M-CK-deficient hearts compared with controls, i.e., LVDP were similar at each pace rate. Thus M-CK appears not to be critical for cardiac function under our experimental conditions. On a different time scale, however, Ventura-Clapier et al. (37) showed that the rate constant for force development in calcium-activated M-CK-deficient ventricular fibers was markedly smaller than in controls, although the developed force by each cross bridge was not altered.
In normal hearts, MM-CK activity constitutes ~75% of the total CK activity. Therefore, PCr/ATP are affected primarily by the reaction of cytosolic MM-CK, operating near equilibrium. Interestingly, in the M-CK-deficient heart PCr/ATP as well as absolute ATP and PCr concentrations were similar to those in wild-type hearts, whereas they are affected almost exclusively through equilibration via Mi-CK. Thus, even without the majority of cytosolic CK, the transgenic hearts are able to maintain their cytosolic phosphorylation potential. Similar observations have been made in the hindlimb skeletal muscle of these mice (33).
The time- and workload-dependent changes in PCr were small, and no consistent increase in intracellular Pi levels was observed. Because the K+-arrested heart was studied at the final stage of the protocol, i.e., ~2 h after the start of perfusion, PCr and ATP levels as well as the NMR-detected CK flux may have become slightly reduced by gradual deterioration of cardiac energy metabolism. Such aging effects were minimal during execution of the saturation-transfer protocol at one workload level. Because of the relative insensitivity of NMR, even at high field strength, and the low tissue mass of mouse hearts (typically 0.175 g wet tissue), rather long measuring times were required that may have affected the stability of the heart preparation. However, the rationale for our protocol was that potential metabolic changes with different workloads could be observed in a single heart preparation.
Although a number of studies have addressed the kinetic behavior of CK in different muscle types, including heart and skeletal muscle, controversy remains about the importance of the enzyme for muscle function and energetics. Part of the controversy may have arisen from conflicting results obtained with different muscle types. On stimulation of skeletal muscle, PCr/ATP gradually declines, while Pi levels rise concomitantly as does the estimated cytosolic free [ADP]. Hence, in skeletal muscle the cytosolic free [ADP] has been implied as an efficient feedback signal to the mitochondria to regulate oxidative ATP synthesis (23). By contrast, in perfused cardiac muscle, workload-related changes in PCr/ATP are often less pronounced and may depend on experimental conditions such as the nature of carbon sources or inotropic agents used (10, 12, 16, 17, 19, 41). In the working dog heart in vivo, PCr/ATP and free ADP levels apparently barely change, at least over the work range studied, suggesting that factors other than free ADP may contribute to the control of oxidative phosphorylation in the heart in vivo (2, 18).
In this study, free [ADP] in wild-type and mutant working hearts were estimated to be on the order of 30-50 µM. These values are near the Michaelis-Menten constant of ADP [Km(ADP)] for mitochondrial oxidative phosphorylation of 25-30 µM, as observed in isolated mitochondria (15), perfused hearts (12), and in vivo skeletal muscle (8, 9). We found that free ADP levels in M-CK-deficient and control animals were similar at each workload level. Free [ADP] tended to be higher in beating than in arrested hearts from both mutants and controls. In transgenic hearts, a significant decrease in free [ADP] between pacing at 600 beats/min and K+ arrest was observed. Unfortunately, the present data lack sufficient accuracy to allow strict conclusions on the extent of workload-related changes in free [ADP] in the M-CK-deficient heart.
Veksler et al. (36) recently observed that in skinned ventricular fibers of M-CK-knockout mice the Km(ADP) of oxidative phosphorylation in the absence of creatine was significantly lower than in wild-type fibers. The addition of creatine markedly increased the rate of oxygen consumption through ADP production by Mi-CK in normal fibers but not in mutant fibers. From these data the authors concluded that the mitochondrial outer membrane in M-CK-deficient ventricles may have an increased permeability for ADP (36). Our calculations of free ADP levels in the heart are largely in agreement with this hypothesis. In transgenic hearts Mi-CK may be expected to equilibrate with the ADP in the mitochondrial intermembrane space, whereas in wild-type mice the calculated ADP largely represents the cytosolic pool. Our finding that free ADP levels and their changes between the various workloads were similar in wild-type and M-CK-knockout hearts suggests equilibration of the ADP pool in the interspace with that in the cytosol in the transgenic heart.
In wild-type hearts, the NMR-observed CK flux will be a summation of the fluxes through the various CK isoenzymes. As a consequence, the kinetic response of individual CK isoenzymes to changes in workload, particularly that of Mi-CK, is still unknown. In this study, we were able to obtain a unique estimate of this Mi-CK-catalyzed flux from a 31P NMR magnetization-transfer examination of M-CK-deficient mouse hearts. We demonstrate for the first time that the steady-state Mi-CK flux is readily observed by NMR and that the apparent rate constant for the reaction in both the beating and the arrested intact heart can be obtained. As mentioned before, at least 90% of the CK activity in the transgenic tissue arises from Mi-CK (36) and the small fraction of BB-CK is not expected to contribute >10% to the CK exchange flux. Recently, quantification of Mi-CK flux in the hindlimb skeletal muscle of these mice did not appear possible (33). At least partially, this can be explained by the higher Mi-CK content of heart compared with skeletal muscle tissue. By comparison, the chemically determined Mi-CK activity in the M-CK-deficient fast-twitch skeletal muscle is only 1-2% of the total CK activity found in homogenates of wild-type muscle.
It has previously been postulated that Mi-CK and myofibril-bound MM-CK operate far from equilibrium and in opposite directions, enabling transport of high-energy phosphates via a CK/PCr shuttle (39). It is commonly assumed that the flux through these compartmentalized CK isozymes should increase with elevated ATP hydrolysis and synthesis rates during work. It should be noted that in transgenic heart a net flux through the Mi-CK reaction cannot exist because of the absence of cytosolic CK. Unfortunately, we cannot quantitatively compare Mi-CK flux with ATP synthesis rate, because we were not able to measure oxygen consumption. However, the observed Mi-CK flux in transgenic mouse heart is several times higher than previously reported rates of mitochondrial ATP synthesis in the heart, which did not exceed 1.3 mM/s at high workload (26). Thus in the transgenic heart Mi-CK-catalyzed exchange should be sufficiently rapid to maintain the reactants near equilibrium. This validates our calculations of free ADP levels in the transgenic heart from CK equilibrium. Interestingly, it may be inferred that because Mi-CK activity is apparently similar in transgenic and normal hearts (33, 36), the Mi-CK reaction should also be sufficiently rapid to maintain near equilibrium under normal steady-state conditions in the wild-type heart, as is generally assumed to be the case for the bulk cytosolic MM-CK isozyme (27). It cannot, however, be ruled out that in wild-type hearts the CK reactions localized at the myofibrils and mitochondria may become (temporarily) displaced from equilibrium, especially during peak workloads or rapid workload transitions.
In Fig. 4 we show that the total CK flux was significantly lower in K+-arrested than in beating wild-type mouse hearts. Remarkably, in transgenic hearts the difference in (Mi-)CK flux between arrest and beating was much less pronounced, with approximately equal changes in RPP and in estimated free [ADP]. Thus in the M-CK-knockout mouse heart an increased rate of mitochondrial oxidative phosphorylation with work is not accompanied by a substantially higher flux through Mi-CK. If we tentatively assume that we can extrapolate these data from the transgenic to the wild-type situation, MM-CK flux may increase significantly with elevated free ADP levels, whereas Mi-CK flux may increase to a much lesser extent. This would imply that in arrested and beating mouse hearts the free [ADP] may approach saturating levels for Mi-CK but may be near the Km(ADP) for MM-CK. This is supported by previously reported values for Km(ADP), which were in the physiological range and were generally higher for the MM-CK than for the Mi-CK reaction (30, 35, 39).
In the arrested heart the apparent kfor and CK flux are approximately equal in wild-type and M-CK-knockout hearts. Remarkably, the Mi-CK-mediated flux in beating mutant hearts was only lower by ~40%, whereas the total CK activity, measured biochemically, had decreased by 74% in M-CK-deficient cardiac tissue. This suggests that the ratio of the steady-state NMR-detected CK flux to the unidirectional CK activity (Vmax) is remarkably higher for Mi-CK than for MM-CK. In other words, relative to its in vitro activity, Mi-CK may contribute much more to the NMR-detected flux than MM-CK. In agreement with this observation, recent studies on purified Mi-CK and MM-CK in solution (35) have shown that at identical Vmax, Mi-CK flux measured by 31P NMR saturation transfer was about twofold higher than MM-CK flux. In that study, the observed fluxes could be explained quantitatively, using kinetic properties of the enzymes in solution (35). The differential contributions of Mi-CK and MM-CK to the total NMR-detected CK flux in vivo may have profound consequences for the interpretation of NMR studies, which aim to probe CK function during muscle contraction.
| |
ACKNOWLEDGEMENTS |
|---|
The authors gratefully acknowledge Dr. B. Wieringa (University of Nijmegen) for providing the M-CK-deficient mouse strain. The authors are grateful to Dr. J. G. van Emous and M. A. Jansen for expert help in setting up the experiments, to Dr. A van den Boogaart for the MRUI software for time-domain analysis of NMR data, to G. Nachtegaal, J. van Os, and G. van Vliet for technical assistance, and to Dr. B. de Kruijff for continuous support and advice.
| |
FOOTNOTES |
|---|
The NMR experiments were performed at the National Netherlands Foundation for Chemical Research High-Frequency NMR Facility, University of Nijmegen.
Address for reprint requests: C. J. A. Van Echteld, Heart Lung Institute and ICIN, Univ. Hospital Utrecht, Heidelberglaan 100, NL-3584 CX Utrecht, The Netherlands.
Received 24 March 1997; accepted in final form 4 June 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Askenasy, N.,
M. Tassini,
A. Vivi,
and
G. Navon.
Intracellular volume measurement and detection of edema: multinuclear NMR studies of intact rat hearts during normothermic ischemia.
Magn. Reson. Med.
33:
515-520,
1995[Medline].
2.
Balaban, R. S.,
H. L. Kantor,
L. A. Katz,
and
R. W. Briggs.
Relation between work and phosphate metabolite in the in vivo paced mammalian heart.
Science
232:
1121-1123,
1986
3.
Bernt, E.,
H. U. Bergmeyer,
and
H. Moellering.
Creatine.
In: Methods of Enzymatic Analysis. New York: Academic, 1974, p. 1772-1776.
4.
Bittl, J. A.,
J. DeLayre,
and
J. S. Ingwall.
Rate equation for creatine kinase predicts the in vivo reaction velocity: 31P NMR surface coil studies in brain, heart and skeletal muscle of the living rat.
Biochemistry
26:
6083-6090,
1987[Medline].
5.
Bittl, J. A.,
and
J. S. Ingwall.
Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study.
J. Biol. Chem.
260:
3512-3517,
1985
6.
Brindle, K. M.
NMR methods for measuring enzyme kinetics.
Prog. NMR Spectroscopy
20:
257-293,
1988.
7.
Brindle, K. M.,
M. J. Blackledge,
J. Challiss,
and
G. K. Radda.
31P NMR magnetization-transfer measurements of ATP turnover during steady-state isometric muscle contraction in the rat hind limb in vivo.
Biochemistry
28:
4887-4893,
1989[Medline].
8.
Brindle, K. M.,
B. Rajagopalan,
D. S. Williams,
J. A. Detre,
E. Simplaceanu,
C. Ho,
and
G. K. Radda.
31P NMR measurements of myocardial pH in vivo.
Biochem. Biophys. Res. Commun.
151:
70-77,
1988[Medline].
9.
Chance, B.,
J. S. Leigh,
B. J. Clark,
J. Maris,
J. Kent,
S. Nioka,
and
D. Smith.
Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady state analysis of the work/energy cost transfer function.
Proc. Natl. Acad. Sci. USA
82:
8384-8388,
1985
10.
Eijgelshoven, M. H. J.,
J. H. G. M. Van Beek,
I. Mottet,
M. G. J. Nederhoff,
C. J. A. Van Echteld,
and
N. Westerhof.
Cardiac high-energy phosphates adapt faster than oxygen consumption to changes in heart rate.
Circ. Res.
75:
751-759,
1994
11.
Forsén, F.,
and
R. A. Hoffman.
Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance.
J. Chem. Phys.
39:
2892-2901,
1963.
12.
From, A. H. L.,
S. D. Zimmer,
S. P. Michurski,
P. Mohanakrishnan,
V. K. Ulstad,
W. J. Thoma,
and
K. Ugurbil.
Regulation of the oxidative phosphorylation rate in the intact cell.
Biochemistry
29:
3731-3743,
1990[Medline].
13.
Goudemant, J. F.,
L. Vanderelst,
Y. Vanhaverbeke,
and
R. N. Muller.
31P NMR kinetics study of cardiac metabolism under mild hypoxia.
J. Magn. Reson.
106:
212-219,
1995.
14.
Hearse, D. J.,
S. M. Humphrey,
A. B. T. J. Boink,
and
T. J. C. Ruigrok.
The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species.
Eur. J. Cardiol.
7:
241-256,
1978[Medline].
15.
Jacobus, W. E.,
and
V. A. Saks.
Creatine kinase of heart mitochondria. Changes in its kinetic properties induced by coupling to oxidative phosphorylation.
Arch. Biochem. Biophys.
219:
167-178,
1982[Medline].
16.
Jeffrey, F. M. H.,
and
C. R. Malloy.
Respiratory control and substrate effects in the working heart.
Biochem. J.
287:
117-123,
1992.
17.
Katz, L. A.,
A. P. Koretsky,
and
R. S. Balaban.
Respiratory control in the glucose perfused heart. A 31P NMR and NADH fluorescence study.
FEBS Lett.
221:
270-276,
1987[Medline].
18.
Katz, L. A.,
J. A. Swain,
M. A. Portman,
and
R. S. Balaban.
Relation between phosphate metabolites and oxygen consumption of heart in vivo.
Am. J. Physiol.
256 (Heart Circ. Physiol. 25):
H265-H274,
1989
19.
Kingsley-Hickman, P. B.,
E. Y. Sako,
P. Mohanakrishnan,
P. M. L. Robitaille,
A. H. L. From,
J. E. Foker,
and
K. Ugurbil.
31P NMR studies of ATP synthesis and hydrolysis kinetics in the intact myocardium.
Biochemistry
26:
7501-7510,
1987[Medline].
20.
Kirkels, J. H.,
C. J. A. Van Echteld,
and
T. J. C. Ruigrok.
Intracellular magnesium during myocardial ischemia and reperfusion: possible consequences for postischemic recovery.
J. Mol. Cell. Cardiol.
21:
1209-1218,
1989[Medline].
21.
Koretsky, A. P.
Insights into cellular energy metabolism from transgenic mice.
Physiol. Rev.
75:
667-688,
1995
22.
Kupriyanov, V. V.,
A. Y. Steinschneider,
E. K. Ruuge,
V. I. Kapel'ko,
M. Y. Zueva,
V. I. Lakomkin,
V. N. Smirnov,
and
V. A. Saks.
Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart.
Biochim. Biophys. Acta
805:
319-331,
1984[Medline].
23.
Kushmerick, M. J.,
and
R. A. Meyer.
Chemical changes in rat leg muscle by phosphorus nuclear magnetic resonance.
Am. J. Physiol.
248 (Cell Physiol. 17):
C542-C549,
1985
24.
Lamprecht, W.,
and
I. Trautschold.
ATP.
In: Methods of Enzymatic Analysis. New York: Academic, 1974, p. 2101-2110.
25.
Lawson, J. W. R.,
and
R. L. Veech.
Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.
J. Biol. Chem.
254:
6528-6537,
1979
26.
Matthews, P. M.,
J. L. Bland,
D. G. Gadian,
and
G. K. Radda.
A 31P-NMR saturation transfer study of the regulation of creatine kinase in rat heart.
Biochim. Biophys. Acta
721:
312-320,
1982[Medline].
27.
Meyer, R. A.,
H. L. Sweeney,
and
M. J. Kushmerick.
A simple analysis of the "phosphocreatine shuttle."
Am. J. Physiol.
246 (Cell Physiol. 15):
C365-C377,
1984
28.
Neubauer, S.,
B. L. Hamman,
S. B. Perry,
J. A. Bittl,
and
J. S. Ingwall.
Velocity of the creatine kinase reaction decreases in postischemic myocardium: a 31P-NMR magnetization transfer study of the isolated ferret heart.
Circ. Res.
63:
1-15,
1988
29.
Perry, S. B.,
J. McAuliffe,
J. A. Balschi,
P. R. Hickey,
and
J. S. Ingwall.
Velocity of the creatine kinase reaction in the neonatal rabbit heart: role of the mitochondrial creatine kinase.
Biochemistry
27:
2165-2172,
1988[Medline].
30.
Saks, V. A.,
G. B. Chernousova,
R. Vetter,
V. N. Smirnov,
and
E. I. Chazov.
Kinetic properties and the functional role of the particulate MM-isoenzyme of creatine kinase bound to heart muscle myofibrils.
FEBS Lett.
262:
293-296,
1976.
31.
Shoubridge, E. A.,
J. L. Bland,
and
G. K. Radda.
Regulation of creatine kinase during steady-state isometric twitch contraction in rat skeletal muscle.
Biochim. Biophys. Acta
805:
72-78,
1984[Medline].
32.
Van der Veen, J. W. C.,
R. De Beer,
P. R. Luyten,
and
D. Van Ormondt.
Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge.
Magn. Reson. Med.
6:
92-98,
1988[Medline].
33.
Van Deursen, J.,
A. Heerschap,
F. Oerlemans,
W. Ruitenbeek,
P. Jap,
H. Ter Laak,
and
B. Wieringa.
Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity.
Cell
74:
621-631,
1993[Medline].
34.
Van Deursen, J.,
W. Ruitenbeek,
A. Heerschap,
P. Jap,
H. Ter Laak,
and
B. Wieringa.
Creatine kinase (CK) in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in muscle CK expression.
Proc. Natl. Acad. Sci. USA
91:
9091-9095,
1994
35.
Van Dorsten, F. A.,
R. Furter,
M. Bijkerk,
T. Wallimann,
and
K. Nicolay.
The in vitro kinetics of mitochondrial and cytosolic creatine kinase determined by saturation transfer 31P-NMR.
Biochim. Biophys. Acta
1274:
59-66,
1996[Medline].
36.
Veksler, V. I.,
A. V. Kuznetsov,
K. Anflous,
P. Mateo,
J. Van Deursen,
B. Wieringa,
and
R. Ventura-Clapier.
Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function.
J. Biol. Chem.
270:
19921-19929,
1995
37.
Ventura-Clapier, R.,
A. V. Kuznetsov,
A. D'Albis,
J. Van Deursen,
B. Wieringa,
and
V. I. Veksler.
Muscle creatine kinase-deficient mice. I. Alterations in myofibrillar function.
J. Biol. Chem.
270:
19914-19920,
1995
38.
Wallimann, T.,
M. Wyss,
D. Brdiczka,
K. Nicolay,
and
H. M. Eppenberger.
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis.
Biochem. J.
281:
21-40,
1992.
39.
Wyss, M.,
J. Smeitink,
R. A. Wevers,
and
T. Wallimann.
Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism.
Biochim. Biophys. Acta
1102:
119-166,
1992[Medline].
40.
Zahler, R.,
and
J. Ingwall.
Estimation of heart mitochondrial creatine kinase flux using magnetization transfer NMR spectroscopy.
Am. J. Physiol.
262 (Heart Circ. Physiol. 31):
H1022-H1028,
1992
41.
Zweier, J. L.,
and
W. E. Jacobus.
Substrate-induced alterations of high energy phosphate metabolism and contractile function in the perfused heart.
J. Biol. Chem.
262:
8015-8021,
1987
This article has been cited by other articles:
![]() |
M. Spindler, R. Niebler, H. Remkes, M. Horn, T. Lanz, and S. Neubauer Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H680 - H687. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Gustafson and J. H. G. M. Van Beek Activation time of myocardial oxidative phosphorylation in creatine kinase and adenylate kinase knockout mice Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2259 - H2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Gustafson and J. H. G. M. Van Beek Measurement of the activation time of oxidative phosphorylation in isolated mouse hearts Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3118 - H3123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mateo, V. Stepanov, B. Gillet, J.-C. Beloeil, and J. A. Hoerter Cardiac performance and creatine kinase flux during inhibition of ATP synthesis in the perfused rat heart Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H308 - H317. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Gustafson and J. H. G. M. Van Beek Activation time of myocardial oxidative phosphorylation in creatine kinase and adenylate kinase knockout mice Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2259 - H2264. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |